发明公开
- 专利标题： AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST
- 专利标题（中）： 氨基喹唑啉化合物作为A2A拮抗剂
-
申请号： EP16747041.8申请日： 2016-02-01
-
公开(公告)号： EP3253390A1公开(公告)日： 2017-12-13
- 发明人: ALI, Amjad , ZHOU, Gang , KUANG, Rongze , LIM, Yeon-Hee , LO, Michael Man-Chu , TING, Pauline C. , BIJU, Purakkattle , RUIZ, Manuel de Lera , DEGRADO, Sylvia J. , TUNG, Alexander L. , HENDERSON, Timothy J. , HONG, Liwu , KIM, Jae-Hun , KIM, David Won-Shik , LEE, Joe F. , WU, Jie , WU, Heping , XIAO, Yushi , YU, Tao , ZHU, Xiaohong , MCCORMICK, Kevin D. , TAGAT, Jayaram R. , XIAO, Dong , KHAN, Tanweer , CAO, Jianhua , BERLIN, Michael , ZHANG, Yonglian
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： 126 East Lincoln Avenue Rahway, NJ 07065-0907 US
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： 126 East Lincoln Avenue Rahway, NJ 07065-0907 US
- 代理机构： Jaap, David Robert
- 优先权： US201562112747P 20150206
- 国际公布： WO2016126570 20160811
- 主分类号： A61K31/517
- IPC分类号： A61K31/517 ; C07D239/84 ; C07D403/12
摘要：
The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.
公开/授权文献
- EP3253390B1 AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST 公开/授权日：2022-04-13
信息查询
IPC分类:
